Incomplete or Partial Hydatidiform Mole
ICD-10 O01.1 · ICD-11 JA02.1

Partial Molar Pregnancy: Next-Step Management After Suction Curettage Fails to Normalise hCG

Clinical Scenario

This protocol addresses a partial molar pregnancy where the size of fetal parts does not deter the use of suction curettage — and suction curettage has already been performed — but hCG levels have not normalised as expected, indicating persistent gestational trophoblastic disease requiring further treatment.

Previous Treatment & Why It Was Not Sufficient

Suction curettage (with anti-D prophylaxis following removal) is the method of choice for removing a partial molar pregnancy when the size of fetal parts does not obstruct its use. The goal of this first-line approach is for human chorionic gonadotrophin (hCG) to return to normal on two samples taken at least 4 weeks apart. When that target is not reached, escalation to the next treatment step is required.

Next-Step Approach (Overview Only)

When hCG fails to normalise after surgical management of a partial molar pregnancy, chemotherapy for gestational trophoblastic neoplasia (GTN) is indicated. The specific regimen is determined by risk stratification using the FIGO 2000 scoring system. The complete protocol — which agents, the risk threshold applied, and the duration — is available via the link below.

▶

Treatment goal: Human chorionic gonadotrophin (hCG) level returns to normal.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/1471-0528.16266

  1. Suction curettage is the method of choice for removal of partial molar pregnancies except when the size of fetal parts deters the use of suction curettage and then medical removal can be used.
  2. Women with GTN may be treated with single-agent or multi-agent chemotherapy.
  3. Women with scores of 6 or less are at low risk and are treated with single-agent intramuscular methotrexate, alternating daily with folinic acid for 1 week followed by 6 rest days.
  4. Women with scores of 7 or greater are at high risk and are treated with intravenous multi-agent chemotherapy, which includes combinations of methotrexate, dactinomycin, etoposide, cyclophosphamide and vincristine.
  5. Treatment is continued, in all cases, until the hCG level has returned to normal and then for a further 6 consecutive weeks.
View source ↗